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Mechanism of ubiquinol oxidation
Crystal structure
Control of ISP domain movementThe cytochrome bc1 complex (bc1) is the mid-segment of the cellular respiratory chain of mitochondria and
many aerobic prokaryotic organisms; it is also part of the photosynthetic apparatus of non-oxygenic purple
bacteria. The bc1 complex catalyzes the reaction of transferring electrons from the low potential substrate
ubiquinol to high potential cytochrome c. Concomitantly, bc1 translocates protons across the membrane,
contributing to the proton-motive force essential for a variety of cellular activities such as ATP synthesis.
Structural investigations of bc1 have been exceedingly successful, yielding atomic resolution structures of
bc1 from various organisms and trapped in different reaction intermediates. These structures have conﬁrmed
and uniﬁed results of decades of experiments and have contributed to our understanding of the mechanism of
bc1 functions as well as its inactivation by respiratory inhibitors. This article is part of a Special Issue entitled:
Respiratory complex III and related bc complexes.
Published by Elsevier B.V.1. Introduction
1.1. Functions of the cyt bc1 complex
Ubiquinol cytochrome c oxidoreductase, commonly referred to as
complex III or the cytochrome bc1 complex (cyt bc1 or bc1), is a
multifunctional, oligomeric membrane protein complex localized to
the inner mitochondrial membrane of eukaryotes or the cytoplasmic
membrane of prokaryotic organisms. This complex is an integral
part of the cellular respiratory chain, contributing to the generation
of electrochemical potential. Cyt bc1 is also an essential part of the
photosynthetic apparatus in purple bacteria, reducing cyt c2 andome c oxidoreductase or cyto-
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.V.returning it to the photosynthetic reaction center for oxidation. In
plants, bc1 complexes show integrated mitochondrial processing
peptidase activity for cleavage of mitochondrial targeting signal
peptides. Cyt bc1 complexes have also been associated with the gen-
eration of reactive oxygen species (ROS). Alteration of bc1 either by
mutagenesis or by chemical treatment results in changes in function
that often lead to devastating consequences.
1.2. Electron-transfer coupled proton-pumping function
The cyt bc1 complex catalyzes the antimycin-sensitive electron
transfer (ET) reaction from lipophilic substrate ubiquinol (QH2)
to cyt c coupled with proton translocation across the membrane
[1]. As a result, for every QH2 molecule oxidized, four protons are
deposited to the positive side of the membrane and two molecules
of cyt c are reduced. This stoichiometry of the ET reaction is given
in the following equation, where QH2 and Q represent lipid-soluble
reduced and oxidized ubiquinone, respectively, c3+ and c2+ repre-
sent oxidized and reduced cyt c, and H+N and H+P represent pro-
tons at the negative and positive sides of the membrane. The
cross-membrane potential thus generated serves as the energy
source for various cellular activities such as the production of ATP
by ATP synthase.
QH2 þ 2c3þ þ 2HþN→
bc1 Q þ 2c2þ þ 4HþP
Table 1
Available coordinates of deposited bc1 structures or fragments determined by X-ray crystallography or EM.
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1RIE B. t. – – – 1.5 ISP-ED 14.6 P21 Iwata [16]
1SQB B. t. Azo Pm – 2.69 0.288 11/11 486 I4122 Xia [58]
3L71 G. g. Azo Pm Q10 2.84 0.281 10/11 486 P212121 Berry TBPf
3L70 G. g. Triﬂoxy Pm Q10 2.75 0.297 10/11 486 P212121 Berry TBP
1SQP B. t. Myx Pm – 2.7 0.314 11/11 486 I4122 Xia [58]
1SQQ B. t. MOAS Pm Q2 3.0 0.295 11/11 486 I4122 Xia [58]
3L72 G. g. Kres Pm Q10 3.06 0.294 10/11 486 P212121 Berry TBP
3H1K G. g. Kres Pm Q10 3.48 0.284 10/11 486 P212121 Berry [108]
3L73 G. g. Triaz Pm Q10 3.04 0.293 10/ 11 486 P212121 Berry TBP
1L0L B. t. Fam Pf – 2.35 0.306 11/11 486 I4122 Xia [109]
3L74 G. g. Fam Pf Q10 2.76 0.286 10/ 11 486 P212121 Berry TBP
2FYU B. t. JG144 Pf – 2.26 0.283 11/11 486 I4122 Xia [57]
3L75 G. g. Fen Pf Q10 2.79 0.275 10/11 486 P212121 Berry TBP
3H1L G. g. Asc Pf, PN Asc 3.21 0.295 10/11 486 P212121 Berry [110]
3CWB G. g. Croc Pf Q10 3.51 0.319 10/11 486 P212121 Berry [111]
1NU1 B. t. NQNO Pf, PN NQNO 3.2 0.296 11/11 486 I4122 Xia [109]
1SQV B. t. UHDBT Pf Q2 2.85 0.285 11/11 486 I4122 Xia [58]
1P84 S. c. HDBT Pf Q6 2.5 0.252 467 C2 Hunte [24]
1SQX B. t. Stg Pf Q2 2.6 0.281 11/11 486 I4122 Xia [58]
2A06 B. t. Stg Pf Q10 2.1 0.258 10/11 486 P212121 Berry [112]
1PP9 B. t. Stg Pf Q10 2.1 0.287 10/11 486 P212121 Berry [112]
1PPJ B. t. Stg Pf Ant 2.1 0.26 10/11 486 P212121 Berry [112]
2BCC G. g. Stg Pf Q10 3.5 0.317 10/11 486 P212121 Berry [112]
3BCC G. g. Stg Pf Ant 3.7 0.321 10/11 486 P212121 Berry [18]
3H1I G. g. Stg Pf Ant 3.53 0.306 10/11 486 P212121 Berry [110]
3H1J G. g. Stg Pf Q10 3.0 0.277 10/11 486 P212121 Berry [18]
1EZV G. g. Stg Pf Q6 2.3 0.254 9/10 467 C2 Hunte [19]
1KB9 S. c. Stg Pf Q6 2.3 0.249 9/10 467 C2 Hunte [91]
1KYOg S. c. Stg Pf – 2.97 0.268 9/10 467 C2 Hunte [87]
3CS5g S. c. Stg Pf – 1.9 0.263 9/10 467 C2 Hunte [88]
2IBZ S. c. Stg Pf Q6 2.3 0.256 9/10 467 C2 Hunte [113]
3CXH S. c. Stg Pf – 2.5 0.256 9/10 467 C2 Hunte [88]
1ZRT R. c. Stg Pf – 3.5 0.358 3/3 221 P21 Berry [20]
2FYN R. s. Stg Pf – 3.2 0.254 3/4 250 I4122 Xia [57]
2QJP R. s. Stg Pf Ant 2.6 0.277 3/4 250 I4122 Xia [21]
2QJK R. s. Stg Pf Ant 3.1 0.266 3/4 250 I4122 Xia [21]
2QJY R. s. Stg Pf Q2 2.4 0.251 3/4 250 I4122 Xia [21]
2YIU P. c. Stg Pf – 2.7 0.29 3/3 467 P21 Hunte [22]
2YBB T. t. Stg Pf Q1 19.0 N/A – 1700 Kühlbrandt [114]
1QCR B. t. – – – 2.7 0.375 11/11 486 I4122 Xia [12]
1BE3 B. t. – – – 3.0 0.32 11/11 486 P6522 Iwata [17]
1BGY B. t. – – – 3.0 0.36 11/11 486 P65 Iwata [17]
1L0N B. t. – – – 2.6 0.297 11/11 486 I4122 Xia [26]
1NTM B. t. – – – 2.4 0.285 11/11 486 I4122 Xia [27]
1NTZ B. t. Q2 – Q2 2.6 0.283 11/11 486 I4122 Xia [27]
1NTK B. t. – – Ant 2.6 0.27 11/11 486 I4122 Xia [27]
1BCC G. g. – – Q10 3.16 0.31 10/11 486 P212121 Berry [18]
3H1H G. g. – – Q10 3.16 0.291 10/11 486 P212121 Berry [18]
a Orga — organisms: B. t., B. taurus; G. g., G. gallus;M. l.,M. laminosus; NOS, Nostoc sp. PCC7120; T. h., T. thermophilus; C. r., C. reinhardtii; P. d., P. denitriﬁcans; R. s., R. sphaeroides; R.
c., R. capsulatus; S. c., S. cerevisiae.
b QP and QN site occupants: Azo, azoxystrobin; Triﬂoxy, triﬂoxystrobin; Myx, myxothiazol; MOAS, MOA Stilbene; Kres, iodo-Kresoxim-dimethyl; Triaz, triazolone; Fam,
famoxadone; Fen, fenamidone; Asc, ascochlorin; Croc, iodo-Crocacin-D; Stg, stigmatellin; Q2, ubiquinone Q2; Q10, ubuquinone Q10; Q6, ubiquinone Q6; Ant, antimycin.
c Reso: resolution or diffraction limit of the crystal in units of Å: 1 Å=10-10 m.
d Quality index; predictive power of model. A lower value of R (free) is better.
e MW: Molecular weight of dimeric bc1 complexes.
f TBP, to be published.
g In complex with cyt c.
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The cyt bc1 complexes from higher organisms also exhibit mito-
chondrial processing peptidase (MPP) activity [2]. The MPP activity
is readily detected in the puriﬁed bc1 complex from plant mito-
chondria such as spinach; it is inactive (but can be activated with
diluted detergents) in the bc1 complex of bovine mitochondria [3].
The MPP activity occurs in the heterodimeric core-1 and core-2
subunits of the mitochondrial bc1 (Mtbc1), which belong to the
pitrilysin family of zinc metallopeptidases, whose members include
insulin-degrading enzyme andmitochondrial MPP in mammals and
in fungi.1.4. Superoxide generation
Under normal respiration conditions, the ET from QH2 to cyt c cat-
alyzed by the bc1 complex is accompanied by the production of a
small amount of superoxide anions presumably through electron
leakage to molecular oxygen [4], which increases dramatically when
the ET within the bc1 complex is blocked by speciﬁc bc1 inhibitors
such as antimycin A or when the ET chain becomes over reduced. The
most likely site of superoxide anion generation under normal ET condi-
tions is at the site of low-potential cyt b heme (bL heme). Mutations
in the cyt b subunit result in not only impaired ET activity but also in-
creased amounts of superoxide anions [5–7]. The role played by the
1280 D. Xia et al. / Biochimica et Biophysica Acta 1827 (2013) 1278–1294
1281D. Xia et al. / Biochimica et Biophysica Acta 1827 (2013) 1278–1294small amount of superoxide anions generated under physiological
conditions is not clear but has been speculated to be part of cellular
signaling mechanisms [8].
2. Structural organization of cyt bc1 complexes
Complex III was among the earliest discovered ET complexes inmito-
chondria. Cyt bwas detected as early as in 1922 [9] and the ﬁrst isolation
procedure for complex III frombovine heartmitochondriawas published
in 1962 [10]. An estimated molecular mass of the complex was reported
in 1965 [11]. It took another 32 years until the ﬁrst crystal structure of
bovine mitochondrial bc1 (Btbc1) was published in 1997 [12].
2.1. Subunit composition of bc1 in various organisms
The subunit composition of bc1 complexes varies signiﬁcantly,
from three subunits in Paracoccus denitriﬁcans and Rhodobacter
capsulatus to as many as eleven subunits in human and bovine mito-
chondria (Table 1). All bc1 complexes contain three redox subunits:
cyt b, having two b-type hemes, a low potential heme bL (Em7=
−90 mV for bacterial bc1 and−30 mV for Btbc1) and a high potential
heme bH (Em7=+50 mV for bacterial bc1 and +100 mM for Btbc1);
cyt c1, containing a c-type heme (Em7=+265 mV for bacterial bc1
and +230 mV for Btbc1); and the iron sulfur protein (ISP), including
a high potential 2Fe–2S iron–sulfur cluster (ISC, Em7=+280 mV for
bacterial bc1 and +250 mV for Btbc1). All additional subunits, referred
to as supernumerary subunits, have no well-established cellular func-
tion except for the subunits core-1 and core-2 in plants, which are
metalloproteases, and thus are believed to contribute to the increased
stability of these complexes. Indeed, bc1 complexes of eukaryotes
carry more supernumerary subunits than those of prokaryotes, con-
sistent with the fact that bc1 complexes of higher organisms are gen-
erally more stable [13]. Furthermore, puriﬁed complex III contains
ubiquinone and various phospholipids [14].
2.2. Structure determination — current status
Crystallographic studies of cyt bc1 complexes have been approached
in many different ways. There are currently 47 deposited experimental
structures in the Protein Data Bank (PDB, Table 1). The ﬁrst crystal
structure obtained was for the ISP extrinsic domain (ISP-ED) fragment
isolated by enzymatic treatment of bovine bc1 [15,16]. Remarkably,
it was the bovine heartmitochondrial bc1 containing no less than 11 dif-
ferent subunits and having a molecular weight of 490 kDa per dimer
whose crystal structurewas the ﬁrst to be determined [12,17,18]. Struc-
tures of bc1 complexes from yeast and non-oxygenic photosynthetic
bacteria Rhodobacter sphaeroides and Rhodobacter capsulatus were
later obtained (PDB IDs: 1EZV, 2QJP, and 1ZRT) [19–21]. More recently,
the bc1 structure from the soil bacterium Paracoccus denitriﬁcans hasFig. 1. Crystal structures in ribbon representation for mitochondrial and bacterial bc1 comp
eleven different subunits are represented as ribbons with the color codes and subunit design
stick models. The iron–sulfur clusters are shown as van der Waals sphere models. The two
gions of the bc1 complex are indicated as IMS (intermembrane space), TM (transmembrane)
R. sphaeroides bc1. Color codes for Rsbc1 are the same as those for Btbc1 except those in red, w
ing subunits in Btbc1. (C) Positions of and distances between iron atoms of prosthetic group
and high potential chains for ET. (D) Ribbon diagram showing the structure of monomeric b
stick models. The axial histidine ligands to the heme groups are also shown as stick models a
PEWY sequence, are shown in magenta and cyan, respectively, and as labeled. (E) Ribbon p
positive and negative sides of the membrane, respectively. The heme c1 along with its two a
the structure of the bovine ISP subunit. The N-terminus of the ISP is on the negative side o
shown as spheres; the two histidine ligands H141 and H161 for the ISC are shown as sti
ISP-ED is shown as a random coil in magenta. (G) Ribbon diagram of the structure of Rscy
for the insertions, which are shown in red. Histidine ligands to the hemes bL (H97 and H19
of the structure of Rscyt c1. Structural features of the subunit are similarly labeled as tho
given as stick models for M185 and H40. (I) Ribbon diagram showing the structure of RsIS
the insertions, which are shown in red. Histidine ligands to the RsISC are show as stick moalso become available [22]. The high sequence similarity of bacterial
bc1 complexes to their mitochondrial counterparts makes them excel-
lent model systems for mitochondrial enzymes. It should bementioned
that structures of related b6f complexes from chloroplasts are also avail-
able [23], but an in-depth discussion of theseworks is outside the scope
of this review. Because of the structural and functional complexities of
the enzyme, all the structures determined by various research groups
have provided information that revealed conformational intricacies of
the complex and thus are not simply duplications of effort.
Structure determination of bc1 in complex with various respirato-
ry inhibitors has been particularly successful with mitochondrial bc1
(Table 1), providing valuable insight into not only the mechanism of
bc1 function but also the mechanisms of inhibition by these inhibitors.
Inhibitors such as stigmatellin play a critical role in stabilizing bc1 in cer-
tain conformations suitable for crystal formation. For example, yeast
bc1 was crystallized in the presence of stigmatellin or HHDBT [19,24];
bc1 from R. sphaeroides can only be crystallized bound to certain types
of inhibitors such as stigmatellin and famoxadone [25]. The functional
signiﬁcance of this conformational stabilization induced by inhibitor
binding will be discussed later.
Cyt bc1 complexes isolated from different organisms and with dif-
ferent protocols have been crystallized utilizing various procedures
and have yielded different crystal forms. Puriﬁcation and crystalliza-
tion procedures can inﬂuence the subunit compositions of isolated
complexes in solution or in crystalline state. While all eleven subunits
of the bovine bc1 have been observed [12,17,26,27], the structures for
yeast [19], chicken [18], and R. sphaeroides [21] each have one missing
subunit. The structure of the mitochondrial bc1 of Saccharomyces
cerevisiae was determined with a monoclonal Fv fragment bound to
the ISP subunit, providing critical contacts for crystal formation [19].2.3. Overall structure and subunit organization of bc1
The crystal structures of mitochondrial bc1 conﬁrmed the results
from electron crystallographic studies [28,29] that the functional
form of bc1 is a dimer, as seen in all structures determined to date,
and revealed the cross-talk of ISP subunits between symmetry-
related monomers. They also conﬁrmed the biochemically deter-
mined subunit composition [30] by showing that all eleven different
subunits in bovine bc1 are present in crystals. Structures of the bc1
complex can be divided into three regions: the membrane spanning,
the inter-membrane space (periplasm in bacteria or positive side of
the membrane), and the matrix (cytoplasm in bacteria or negative
side of themembrane) regions (Fig. 1A). There are 13 transmembrane
(TM) helices in a monomer of bovine mitochondrial bc1; eight are
contributed by the cyt b subunit and one each comes from cyt c1,
the ISP, subunits 7, 10, and 11. For bacterial bc1 (Fig. 1B), the total num-
ber of TM helices is reduced to 10 or 11 for a monomer, depending on
the presence or absence of the only supernumerary subunit. Inlexes. (A) Structural model of the dimeric bc1 complex from bovine mitochondria. The
ations given on the left. Prosthetic groups such as the hemes bL, bH, and c1 are shown as
black horizontal lines delineate the boundaries of the membrane bilayer. The three re-
and matrix regions, respectively. (B) Structural model of the photosynthetic bacterium
hich represent insertions in cyt b, cyt c1 and ISP subunits in relation to the correspond-
s. Hemes bL, bH and c1 as well as 2Fe–2S clusters are labeled. Arrowed lines indicate low
ovine cyt b. Eight TM helices are labeled. The two b-type hemes bL and bH are shown as
nd labeled. The two conserved and functionally important motifs, the cd1 helix and the
resentation of the structure of bovine cyt c1. Btcyt c1 has its N- and C-terminus on the
xial ligands BtM160 and BtH41 are shown as stick models. (F) Ribbon diagram showing
f the membrane, whereas the C-terminus is on the positive side. The 2Fe–2S cluster is
ck models and are labeled. The ﬂexible linker or neck between the TM helix and the
t b. Structural features of the subunit are similarly labeled as those in Btcyt b except
8) and to bH (H111 and H212) are shown as stick models. (H) Ribbon representation
se in Btcyt c1 except for the insertions, which are shown in red. Heme c1 ligands are
P. Structural features of the subunit are similarly labeled as those in BtISP except for
dels for H131 and H152.
Table 2
Edge-to-edge distances (Å, upper triangle) and calculated ET rates (s−1, lower triangle) between pairs of prosthetic groups in dimeric bc1 of space group I4122 with the ISP in
b-position.
bH(1) bL(1) c1(1) ISP(1) bH (2) bL(2) c1(2) ISP(2)
bH(1) – 7.9 41.9 29.1 26.9 21.2 56.5 48.1
bL(1) 1.1×108 – 27.5 22.4 21.2 8.9 40.4 34.2
c1(1) 2.0×10−13 5.3×10−4 – 27.7 56.5 40.4 49.5 54.7
ISP(1) 1.6×10−5 0.85 2.1×10−5 – 48.1 34.2 54.7 59.8
bH(2) 4.9×10−5 0.83 2.4×10−22 4.2×10−17 – 7.9 41.9 29.1
bL(2) 0.83 4.7×106 7.2×10−12 5.4×10−8 1.1×108 – 27.5 22.4
c1(2) 2.4×10−22 7.2×10−12 8.0×10−19 7.2×10−22 2.0×10−13 5.3×10−4 – 27.7
ISP(2) 4.2×10−17 5.4×10−8 7.2×10−22 4.2×10−25 1.6×10−5 0.85 2.1×10-5 –
The calculated ET rates (ket, s−1), using the empirical expression logket=15.2−0.61R−3.1 (ΔG-λ)2/λ for weakly coupled donor-acceptor pairs [31], are based on edge-to-edge
distances of R in Å, a driving force (ΔG°) under standard conditions of −0.13 eV for the donor–acceptor pairs of bL–bH and bH–c1, of −0.15 eV for the bH-ISP pair, of 0 eV for the
pairs of bH–bH, bL–bL, c1–c1, and ISP-ISP, of−0.26 eV for the bL–c1 pair, and−0.28 eV for the bL-ISP pair, and a reorganization energy (λ) of 1.0 eV recommended for protein media.
1282 D. Xia et al. / Biochimica et Biophysica Acta 1827 (2013) 1278–1294mitochondrial bc1, supernumerary subunits 1, 2, 6 and 9 are exclusively
present in the matrix region. Notice, however, that the subunit 9 is
absent in yeast bc1 and none of these subunits are present in bacterial
bc1. Subunit 8 is associated with cyt c1 at the intermembrane space
side of the membrane for mitochondrial bc1. Again, this subunit is ab-
sent in the bc1 of bacteria.
From the ﬁrst crystal structure of Btbc1 [12], the positions of the
iron atoms in prosthetic groups and distances between them were
initially obtained by anomalous difference Fourier maps (Fig. 1C)
and ET rates between pairs of prosthetic groups, serving as weakly
coupled donors and receptors, can be estimated based on the empir-
ical approximation for intraprotein ET transfer (Table 2) [31]. The
permissible ET routes thus obtained were mostly consistent with
proposed high and low potential chains. Surprisingly, the shortest dis-
tance between the iron–sulfur cluster (ISC) and the edge of c1 heme is
27.7 Å, which corresponds to an estimated ET rate of 2.1×10−5 s−1.
This ET rate does not permit the normal function of bc1. This conundrum
was soon resolved, as it was discovered that the distance between
the ISC and cyt c1 is not a ﬁxed parameter. Several reﬁned crystal struc-
tures of bovine as well as chicken bc1 revealed markedly different posi-
tions of the ISP-ED (Table 3), whereas the positions for b and c1 hemes
remained unchanged [17,18].2.4. Structures of the bc1 subunits essential for ET function
Three subunits are essential for the ET function of bc1: cyt b, cyt c1
and ISP. In eukaryotes, cyt b is the only subunit encoded and synthe-
sized by mitochondria; it is entirely embedded in the membrane and
consists of two helical bundles: helices A–E form the ﬁrst and helices
F–H belong to the second. The two b-type hemes are intercalated into
the ﬁrst bundle between the TM helices B and D. As was correctly de-
termined by genetic studies, the heme bL was coordinated by the two
histidine residues H83 and H182 (Bt cyt b) and the heme bH was
liganded also by two histidine residues H97 and H196. The two b-type
hemes are part of the active sites that catalyze opposite reactions: the
QP (QO near bL heme) site, located near the inter-membrane space
(IMS) in mitochondria or on the periplasmic side in bacteria, provides
access to lipid-soluble QH2 for oxidation, and the QN (QI near bH
heme) site, situated closer to the matrix (mitochondria) or cytoplasm
(bacteria), carries out the reduction of ubiquinone. The two bundles
contact each other on the negative side of the membrane, but separate
on the positive side, creating a gap that is bridged by the cd helices (cd1
and cd2) and by the EF loop. A hydrophobic pocket below the cd helices
and next to the ef helix is the ubiquinol oxidation site or QP pocket
(Fig. 1D), which was ﬁrst visualized by the binding of the QP speciﬁc
inhibitor myxothiazol [12]. The location of the ubiquinone reduction
site or the QN site was inferred from the antimycin-binding pocket of
cyt b [12]. There are four prominent surface loops: three are on the pos-
itive side (AB, CD, and EF) and one is on the negative side (DE) (Fig. 1D).Both the cyt c1 and ISP subunits are anchored to the membrane by
TM helices with their respective extramembrane domains localized
on the positive side of the membrane (Fig. 1E and F). Whereas the
TM helix of ISP is N-terminal to its extrinsic domain, the one for cyt c1
is C-terminal. The extrinsic domain of the ISP subunit (ISP-ED) was
found to be largely disordered in native and completely disordered
in myxothiazol-bound bc1 crystals of space group I4122 [12,32], but
was found ordered in different positions in crystals of space groups
P212121, P21, P6522, and P65 [17,18] (Table 3).
When sequences ofMtbc1 and Rsbc1 are compared, the latter often
possesses more insertions than deletions [21,33]. Remarkably, the in-
sertions occur only on or near the periplasmic or cytoplasmic side and
not within the transmembrane region (Fig. 1B). An understanding of
the functions of these additions or deletions may provide insight into
the evolutionary process that transformed the bacterial enzyme into
its mitochondrial equivalent. When compared to the bovine cyt b, the
structure of bacterial cyt b is essentially identical. Rs cyt b features two
terminal extensions and two major insertions. The N- and C-terminal
extensions are 22 and 29 residues long, respectively; they each contains
extramembrane helix named a0 and i, respectively (Fig. 1G). One inser-
tion (de helix) is in the cytoplasmic DE loop and another (ef1 helix) is
found after the ef helix on the periplasmic side. Thus, except for the
ef1 helix, all extensions and insertions are located on the N-side of the
membrane and they likely function to maintain the structural integrity
of the quinone reduction site by preventing potential electron leakages
and by safeguarding channels for proton inﬂux. On the periplasmic side,
there is one large insertion of 18 residues (310–327) between Pro285
and Asn286 (Bt cyt b) containing the ef1-helix, which protrudes from
cyt b laterally and runs parallel to the membrane surface. This insertion
occurs only in species that belong to the phylum proteobacteria. How-
ever, it is functionally important, as the point mutation S322A (Rs cyt b)
or deletion of residues 309–326 (Rs cyt b) signiﬁcantly lowers the
enzyme activity [34]. The ef1-helix may play an important role in
lipid binding, as features of several potential lipid molecules are visible
in the electron density. It also enhances crystal contacts through aro-
matic stacking interaction between a pair of Trp313 residues from adja-
cent cyt b subunits [21].
Structure-based sequence alignment revealed that cyt c1 of Rsbc1
has undergone both insertions and deletions relative to mitochondrial
complexes [21]. Apart from the two small insertions in the Rs cyt c1
after Glu52 (4 residues) and Ala146 (3 residues), there is one large inser-
tion between Gly109 and Gly127 (Rs cyt c1). It features a short helix
(H1d) that protrudes from cyt c1 into the lipid bilayer sealing off a com-
partment between cyt c1 and cyt b (Fig. 1H). The only insertion in cyt c1
that may replace the function of a supernumerary subunit is the
18-residue insertion starting at position 162 (Rs cyt c1), which is spatially
close to the head domain of ISP. This region is characterized by an
increased disorder (high B-factor) but features a stabilizing disulﬁde
bridge (Rs cyt c1, Cys145–Cys169), whose existence is in agreement with
recently published data [35,36]. Approximately 8 Å from the ISP-ED
Table 3
Conformational switch of the ISP-ED as indicated by the iron atoms of the ISC in different crystal forms and with different bound inhibitors.
Space group Organism Ligand at QP site ISP position Normalized ISC ano peaka ISC-heme c1 distance (Å) Estimated ET rate (s−1) Ref.
I4122 B. t. None mc 0.45 27.7 2.1×10−5 Xia [32]
I4122 B. t. Azoxystrobin mc 0.36 27.7 2.1×10−5 Xia [57]
I4122 B. t. MOAS mc 0.23 27.7 2.1×10−5 Xia [57]
I4122 B. t. Famoxadone bd 1.02 27.7 2.1×10−5 Xia [57]
I4122 B. t. Stigmatellin bd 1.20 27.7 2.1×10−5 Xia [57]
I4122 B. t. UHDBT bd 0.96 27.7 2.1×10−5 Xia [57]
P65 B. t. None I1e – 23.6 0.007 Iwata [17]
P6522 B. t. None c1f – 7.8b 2.9×107 Iwata [17]
P212121 B. t. Kresoxim-dimethyl I2 – 14.9b 1361 BerryTBP
P212121 B. t. Stigmatellin b – 27.7 2.1×10−5 Berry [112]
C2 S. c. Stigmatellin b – 26.8 7.5×10−5 Hunte [19]
P212121 B. t. Azoxystrobin I2g – 14.6b 2074 BerryTBP
C2 R. s. Stigmatellin b – 27.0 5.7×10−5 Xia [21]
P21 R. s. Stigmatellin b – 27.0 5.7×10−5 Xia [21]
TBP — to be published.
a Normalized anomalous difference Fourier peaks for the Fe atoms in the ISP subunits [58].
b Distances are measured from ND2 of H161 of ISP to closest atom on the ring of heme c1.
c ISC at b-position is of low occupancy.
d ISC at b-position is of high occupancy.
e ISC at intermediate-1 position.
f ISC at c1-position.
g ISC at intermediate-2 position.
Fig. 2. Q-cycle mechanism. The Q cycle mechanism deﬁnes two reaction sites: quinol
oxidation (center P or QP) and quinone reduction (center N or QN). It takes two quinol
oxidation cycles to complete. At ﬁrst, a QH2 moves into the QP site and undergoes ox-
idation with one electron going to cyt c via the ISP and cyt c1 (high-potential chain),
and another ending in the QN via hemes bL and bH (low-potential chain) to form a
ubisemiquinone, and releasing its two protons to the Ψ+ site of the membrane. The
second QH2 is oxidized in the same way at the QP site but its low potential chain elec-
tron ends up reducing the ubisemiquinone radical. Reduced QH2 is released upon pick-
ing up two protons from the negative side of the membrane. As a result of the Q cycle, 4
protons are transferred to the Ψ+ side, 2 protons are picked up from the Ψ− side and
effectively only one QH2 molecule is oxidized.
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ably functions as an extended arm to limit its motion. Compared to
mitochondrial cyt c1, two large deletions, near residues Thr77 and
Ser92 (Rs cyt c1), respectively, result in the loss of bridging interactions
between the two cyt c1 subunits within the dimer.
Structure-based sequence alignment shows one insertion in the se-
quence of Rs ISP. This insertion (residues 97–108) is 20–25 Å from
the 2Fe–2S cluster and contributes to the surface of ISP-ED that faces
away from cyt c1; it forms a globular structure containing three
β-turns and one inverse γ-turn (Fig. 1I). There is an intricate network
of interactions employing both main chain and side chain atoms,
suggesting a stabilizing role for this insertion. Disruption of this net-
work of interactions by more than one point mutation led to the loss
of the ISP subunit in the complex [37].
3. Mechanism of ET-coupled proton pumping from a structural
perspective
3.1. Q-cycle and bifurcation of electron ﬂow at the QP site
Unlike other ET complexes of the respiratory chain, the bc1 com-
plex uses ubiquinol to shuttle protons across the membrane and
does so via the Q-cycle mechanism [38,39] that obligates the bc1 com-
plex to have a quinol oxidation site, a quinone reduction site and a
bifurcated ET at the quinol oxidation site (Fig. 2). The critical experi-
ments that led to the Q-cycle hypothesis included oxidant-induced
cyt b reduction in the presence of the bc1 inhibitor antimycin
[40,41], identiﬁcation of ISP as an oxidation factor [42], and the reac-
tion stoichiometry of two protons translocated across the membrane
for every electron transferred [43]. The identiﬁcation of two postu-
lated separate quinone reduction and quinol oxidation sites in the crys-
tal structure further validated the “Q-cycle” mechanism [12].
The key step in the Q-cycle mechanism is the separation of the two
electrons of the substrate QH2 at the QP site. The ﬁrst electron of quinol
is transferred to the “high-potential chain”, consisting of the ISP, cyt c1
and cyt c. The second electron is concomitantly passed through the
“low-potential chain” consisting of hemes bL and bH, to reduce ubiqui-
none or ubisemiquinone bound at the QN site. This mechanism ensures
a proton pumping efﬁciency of two protons per electron transferred
to cyt c.
Although the Q-cycle hypothesis has received much experimental
support, it does not explain why the two electrons do not both followthe high potential chain, which is thermodynamically more favorable
[44]. In fact, the chemistry underlying the electron bifurcation at the
QP site has been hotly debated, resulting inmany proposedmechanisms,
including the catalytic switch model [45], the double-occupancy Qo
site model [46], the proton-gated charge-transfer mechanism [47],
the logic-gated ﬁt mechanism [48], a sequential model [49,50], a con-
certed model [51–53], more recently, the R-complex model [54], the
double-gated model [55], and the proton-transfer gating mechanism
[56]. A mechanism named “surface-afﬁnity modulated ISP motion
switch hypothesis” was proposed on the basis of the observed
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in the presence of various bc1 speciﬁc inhibitors [57,58]. This and similar
models [59] provide a simple explanation for the bifurcated ET at the QP
site and its experimental basis will be outlined in the following sections.
3.2. Observed conformational change in the extrinsic domain of the ISP
subunit in various crystal forms and in the presence of respiratory inhibi-
tors
In the ﬁrst Btbc1 structure reported, the ISP-ED is at the b-position
[12]. As shown in Table 2, the shortest edge-to-edge distance be-
tween the ISC and heme c1 is 27.7 Å; ET along the high potential
chain is not permissible under such conditions. Subsequent structure
determinations showed ISP-ED in a number of different positions: near
cyt c1 (c1-position) or at least two intermediate locations (I1- or
I2-positions) (Table 3). When the ISP is at the c1-position (Bt P6522), the
shortest edge-to-edge distance of cyt c1 heme to atom ND2 of BtH161 of
the ISP, which is a ligand to the ISC, is measured at 7.8 Å, corresponding
to an estimated ET rate of 2.9×107 s−1. The two intermediate distances
found in deposited PDB coordinates are I1-position of 23.6 Å (Bt P65)
and I2-position of 14.9 Å (Gg P212121). These distances would give ET
rates of 0.007 s−1 and 1361 s−1, respectively.
Crystallographic studies in the presence of various inhibitors have
been conducted for Btbc1, resulting in the observation of various con-
formations of the ISP-ED. Crystallographic studies of binding of QP site
inhibitors to bovine bc1 led to the classiﬁcation of two types of inhib-
itors: Pf and Pm inhibitors [58]. The Pf inhibitors immobilize or ﬁx the
conformation of the ISP-ED at the b-position and include the classic
inhibitors stigmatellin, n-undecyl hydroxy dibenzothiazole (UHDBT),
HDBT and n-nonyl quinoline N-oxide (NQNO), modern pesticides like
famoxadone, 3-anilino-5-(2,4-diﬂuorophenyl)-5-methyl-oxazolidine-
2,4-dione (JG144), fenamidone and the natural inhibitor ascochlorin
aswell as iodo-crocacin-D (a compound optimized fromnatural crocacin
D). Pm inhibitors release the ISP-ED from the b-position. This class of
inhibitors contains the well-known natural inhibitor myxothiazol and
also the synthetic compoundsmethoxy-acrylate stilbene and the widely
used pesticides azoxystrobin, kresoxim methyl, triﬂoxystrobin, and
triazolone.
Recently, structures of Ggbc1 (chicken bc1) in complex with either
Pf or Pm inhibitors have been deposited into the Protein Data Bank
(Table 1). In all Pf inhibitor complexes, the ISP-ED is found in the
b-position, whereas in all Pm complexes, the ISP-ED is located in the
I2-position. These structures are in complete agreement with what
has been observed in inhibitor binding studies of Btbc1 [12,26,32,57,58].
3.3. Domain movement is necessary but not sufﬁcient for bifurcated
electron ﬂow
The crystallographically observed inherent mobility of the ISP-ED,
as the ISP-ED was not well ordered in the ﬁrst bc1 structure [12] and
the variable distances between the ISC and cyt c1 heme in subsequent
structures [17,18], led to the proposal of ET by domain movement to
bridge the 27.7 Å gap [17,18]. Experimental attempts to immobilize
the ISP-ED by mutations or by cross-linking in bacterial and yeast
bc1 complexes have invariably inactivated the enzyme [60–67], indi-
cating that the mobility of the ISP-ED is necessary for the bifurcated
ET of bc1. However, whether the observed mobility of the ISP-ED is
sufﬁcient to guarantee an obligatory electron bifurcation is question-
able. First, the observed rate (80,000 s−1) of ET from the ISP to cyt c1
in Rsbc1 [68] is much faster than the turnover rate of the bc1 complex
(~900 s−1), meaning that both electrons can potentially follow the
high-potential chain. Second, the observed ET rate between the ISP
and cyt c1 is independent of pH and the redox potential of the ISP, in-
dicating that the rate is not limited by the electron transfer event
according to the Marcus theory. Instead, a gating or control mecha-
nism for ISP-ED movement must be in place [69]. Third, addition ofpuriﬁed ISP-ED to a preparation of bc1 without the ISP-ED only par-
tially restores bc1 activity [70]. Fourth, free motion of ISP cannot ex-
plain the total inhibition of bc1 by antimycin, which acts remotely at
the QN site. Thus, the mobility of ISP-ED itself is not sufﬁcient to sup-
port a bifurcated ET at the QP site.
3.4. Capture and release of the ISP-ED is an inherent property of the cyt b
subunit
The ISP subunits assemble into the bc1 dimer with their respec-
tive N-terminal TM helices anchored in one monomer while their
C-terminal ISP-EDs reach over to interact with the other monomer
(Fig. 1A and B). A linker region (residues 62–74 in the Bt ISP), whose
ﬂexibility is essential for the electron-shuttling function of the ISP,
provides the connection between the TM helix and the ISP-ED (Fig. 1F
and I). The ISP-ED binds to the ISP-docking surface on the cyt b subunit
through the small tip area that surrounds the 2Fe–2S cluster and thus
forms a part of the QP site. The tip of the ISP features a smooth, rigid,
and largely hydrophobic surface suited toﬁt into awell-deﬁned docking
site.
Certain Pf inhibitors (stigmatellin and UHDBT) not only immobi-
lize the ISP-ED but also increase its midpoint potential (Em7). Both
observations were explained by the formation of a direct H-bond be-
tween an oxygen atom of the inhibitor and the presumably proton-
ated BtH161 — a ligand of the 2Fe–2S cluster. In particular, the
formation of this H-bond had been deemed essential for the ﬁxation
of the ISP-ED at the b-position. Structural studies of a number of addi-
tional inhibitor-bc1 complexes have appeared to support this notion
[24,54,71]. However, this hypothesis is not compatible with the pro-
posed QP site chemistry for ubiquinol oxidation, which involves the for-
mation of a hydrogen bond between the substrate ubiquinol and the
ISP, because ubiquinol cannot act as an inhibitor. Surprisingly, the bc1-
famoxadone and bc1-JG144 complexes showed the ISP-ED in the ﬁxed
state as observed in the stigmatellin complex, yet there was no direct
ISP-inhibitor interaction (Fig. 3A and B). It is therefore clear that direct
H-bonding between the ISP-ED and the bound inhibitor may contribute
to, but does not cause the conformational ﬁxation of the ISP. Instead,
the conformational switch of the ISP is an intrinsic property of the bc1
complex.
If the conformational switch or capture-and-release of the ISP-ED
is indeed an intrinsic property of bc1, an important question is whether
the ISP-ED can undergo the ﬁxed tomobile conformational transition
in the absence of inhibitor binding, as this is highly relevant to bc1
function under physiological conditions. Preliminary results from
redox-coupled crystallographic studies of Btbc1 [72,73] showed
that ISP-ED is in the ﬁxed position when the complex is fully re-
duced, whereas it is mobile when oxidized. Thus, conformation tran-
sition of the ISP-ED can also be achievedwith electronic signals, most
likely from ET in the cyt b subunit.
3.5. Mechanism of ISP-ED's capture and release
The ISP binding surface of cyt b has the appearance of a volcanic
crater; most residues that contribute to the crater are hydrophobic
in nature and only 16 of them have side chains facing the ISP. Of
these residues, all but one are located on the CD and EF loops, which
connect helices C and D, and helices E and F, respectively (Fig. 1D and
G). Two structural motifs within the CD and EF loops, the conserved
cd1 helix and the PEWY sequence motif, undergo large movements
upon binding of QP site inhibitors. Inhibitor binding generally causes
the PEWY motif, as measured for residue BtP271 of bovine cyt b, to
back away in a unidirectional fashion from the QP pocket by more
than 1.5 Å, whereas the direction in which the cd1 helix moves clearly
correlates with the type of bound inhibitors when compared to the
structure of inhibitor-free bc1. Invariably, the inhibitors that are known
to promote the mobile state of the ISP-ED cause a negative shift,
Fig. 3. Binding of substrate, inhibitor and lipid molecules to the cyt bc1 complex. (A) Hydrogen bonding interaction between stigmatellin and the ISP. In this ﬁgure, much of the
protein structures of cyt b and ISP are omitted for clarity to illustrate the H-bond between stigmatellin and the ISC. All residues, the ISC, and stigmatellin are shown as
ball-and-stick models and as labeled. The distance between BTH161, one of the 2Fe–2S ligand, and stigmatellin is shown as 2.8 Å. (B) No hydrogen bonding is observed between
famoxadone and the ISP. Binding of famoxadone arrests the ISP-ED motion. But the closest distance between BTH161 and the ISP is >6 Å. (C) Interaction of the protein environment
at the QN site of the cyt b subunit with bound substrate ubiquinone with two isoprenoid repeats. Secondary structure elements surrounding the QN pocket, including portions of the
N-terminal helix a, TM helices A, D, and E, and extra-membrane loops A and DE, are shown and are labeled. Residues interacting with bound substrate and the bH heme are drawn in
stick models and are labeled with carbon atoms in yellow, nitrogen in blue, oxygen in red, and iron in orange. H-bonds are indicated with pinkish dotted lines. Water molecules are
shown as isolated red balls. The residues that are with magenta labels confer inhibitor resistance. The substrate ubiquinone, caged in Fo-Fc electron densities calculated with reﬁned
phases after ligand being omitted and contoured at the 3σ level in dark green, are drawn as ball-and-stick models with carbon atoms in black, nitrogen in light blue, and oxygen in
red. Additionally, the two bound water molecules are enclosed in the Fo-Fc electron density in cyan calculated with reﬁned phases obtained with the waters omitted and contoured
at 3σ. (D) Binding environment of the bound lauryl oleoyl phosphatidyl ethanolamine (PE) in the structure of Rsbc1. The modeled lipid is located near the N-side and its binding
environment is shown.
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lead to a positive displacement of the cd1 helix; here the positive or
negative denotes the direction of the shift relative to the
inhibitor-free enzyme. More precisely, the positional shifts of the
cd1 helix are roughly parallel to the membrane surface; the positive
shift signiﬁes a displacement of the cd1 helix swinging outward away
from the QP pocket leading to an expanded QP pocket, and the negative
shift indicates an inward displacement. The importance of the cd1 helix
in bc1 function is also manifest in its high degree of sequence conserva-
tion, which reaches 98.5% identity (averaged over 14 residues), based
on an analysis of a 5355 non-redundant cyt b sequence set, as compared
to the cd2 helix (73.5% for 9 residues) or to thewhole subunit (75.2% for
379 residues), a fact that has been known for a long time but had no
clear explanation [74].
The mechanism that induces this dramatic transition in ISP-ED
conformation and how the signal is transmitted from the source(the binding of inhibitor to the QP site) to the target residue(s) that
capture the ISP-ED have been investigated [57]. Two possible interac-
tion forces at the ISP-ED binding surface were looked at separately
without assuming that they were mutually exclusive: (1) changes in
hydrogen bonding patterns and (2) adjustments in van der Waals
(vdw) interactions expressed as changes of surface complementarity.
It is conceivable that, if the bifurcation of ET requires a control mecha-
nism for ISP-ED conformational switch, the formation of a large number
of strong H-bonds between the docked ISP-ED and the docking site
would be unfavorable for the switch for energetic reasons. Indeed,
in the structures where the ISP-ED is in the ﬁxed conformation or
b-position as seen in the complexes of Pf inhibitor famoxadone,
stigmatellin, JG144, NQNO, UHDBT, ascochlorin or crocacin as few as
seven H-bonds are formed between the ISP and cyt b. While two of
them are permanent and found in the neck region of the ISP of all struc-

















































Fig. 4. Control of the ISP-ED motion switch and the proposed mechanism for bifurca-
tion of electron ﬂow at the QP pocket. The structural components necessary for the
control of the ISP conformational switch are illustrated in this cartoon rendition of
the QP pocket. The PEWY motif and cd1 helix in gray represent a native (Resting) con-
ﬁguration. The ISPs in yellow and magenta are in oxidized and reduced forms, respec-
tively. The heme bL is red when it is reduced. The PEWY motif in blue stands for the
open conﬁguration as in the state with a bound QP site inhibitor. The cd1 helix in red
symbolizes the conformation (On) as in the presence of a Pf inhibitor occupying the
distal site (pink), and the cd1 helix in green shows the conformation (Off) when a
Pm inhibitor is occupying the proximal site (purple). Cyt c1 is shown in orange.
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atoms of the backbone are employed by the ISP for non-permanent
H-bonds. The non-permanent H-bonds disappear when Pm inhibitors
like azoxystrobin, MOA-stilbene or myxothiazol are bound. Extensive
mutagenesis studies in the cyt b subunit including the RsK287–S151
dyad and ScY278 (RcY302) [7,57] appear to rule out that the change in
H-bonding pattern controls ISP capture and release.
When the van der Waals interactions were examined (expressed
in terms of changes in contact area (CA) and in surface complemen-
tarity (SC) of the two interacting surfaces between the cyt b and the
ISP-ED), it was clear that changes in CA and SC are correlated to the
movement of the cd1 helix. As one goes from Pf- to Pm-type inhibi-
tors, there is a decrease in the CA and most notably a nearly 40%
loss in SC. Since the ISP-ED has shown no sign of internal plasticity
and the cd1 helix is known to undergo a shear motion as inhibitors
bind to the QP site, the change in shape complementarity caused by
the cd1 motion represents a possible mechanism that could account
for the change in binding afﬁnity of cyt b toward the ISP, thus regulat-
ing ISP conformational dynamics.
Although the cause and effect relationship is apparent for the
binding of different types of inhibitors and the conformational switch
of the ISP-ED, the same relationship cannot be said with absolute cer-
tainty for the movement of the cd1 helix and the ISP-ED switch. How-
ever, circumstantial evidence does exist. (1) Inhibitors such as
famoxadone do not contact the ISP-ED directly. Thus capture of the
ISP-ED by famoxadone binding likely follows the sequence of inhibi-
tor binding to cyt b, followed by cd1 helix movement, changing the
shape of the ISP-ED binding crater, and subsequent ISP-ED arrest.
(2) ISP-ED conformational switch can be mediated by changes in
redox conditions in the absence of inhibitors. Under such conditions,
the reduction of cyt b likely signals the movement of the cd1 helix,
leading to capture of the ISP-ED. (3) Even before the role of the cd1
helix was proposed, the activity of bc1 was found to be dependent
on the size of the residue at position 155 of the cd1 helix (Rsbc1).
The larger the size of the side chain, the less activity the bc1 complex
has [75]. Examination of bc1 structure indicates that mutation of res-
idue RsS155 to a larger residue would limit the movement of the cd1
helix, leading to inactivation.
3.6. Afﬁnity controlled ISP conformational switch hypothesis for bifurcated
ET at QP site
A control mechanism, called the “binding afﬁnity modulated
ISP-ED motion switch hypothesis” has been proposed, allowing mod-
ulation of the binding afﬁnity toward the ISP-ED by the cyt b subunit
[57,76] (Fig. 4). The basic principle of the hypothesis is that the cyt b
subunit controls the rate of electron ﬂow in the high potential chain
by controlling the ISP-ED conformation state and regulating the dis-
tance between the ISC and heme c1, thus ensuring the bifurcated
ﬂow of the two electrons from ubiquinol. The following sequence of
events during the QH2 oxidation may take place: (1) In the absence
of any substrate at the QP site, the ISP-ED is capable of sampling
the QP site frequently. The binding surface on the side of cyt b is in
a resting state in a sense that its shape matches that of the ISP-ED
sufﬁciently well to keep it in proximity but not enough to hold it
in a ﬁxed conformation. This state is characterized by the ef helix in
the “closed” position and the cd1 helix in the “resting” position.
(2) When a substrate QH2 molecule enters the catalytic site (Fig. 4,
step 1), it proceeds to the distal part of the QP pocket. To accommo-
date the QH2 molecule, the ISP-binding crater widens by moving
the cd1 switch toward the “on” position and by pushing the ef helix
to the “open” position. The reshaping of the ISP-binding site increases
its afﬁnity for the ISP-ED to the point of its ﬁxation in situ. As a result,
a transient cyt b-QH2-ISP complex forms, which features an H-bond
from BtH161 of the ISP to the substrate. The distance from the ISC to
heme c1 is now ﬁxed at 27.7 Å. (3) As the ﬁrst electron is beingtransferred to the ISP (Fig. 4, step 2), the one-electron carrier remains
ﬁxed in place, and the second electron in the Q radical has to enter the
low-potential chain, a process that likely occurs simultaneously with
the ﬁrst ET and possibly via residue BtY131, which undergoes a large
conformational change when bound with UHDBT [58]. The notion of
a concerted ET is supported by the inability to detect an
ubisemiquinone radical on the EPR time scale and by the observation
of simultaneous reduction of the ISP and bL heme in pre-steady-state
kinetic analysis of the ET at the QP site [52]. We speculate that as
the second electron moves toward the bH heme (Fig. 4, step 3), the
proton translocation is accomplished. It is worthwhile to emphasize
that because the reduced ISP is ﬁxed at the b-position, which is at a
non-permissive distance from c1 heme for ET, the ﬁrst electron re-
mains in the ISP. This simple mechanism ensures the bifurcated ET
of the two electrons. (4) The Q molecule exits via the proximal bind-
ing site in the QP pocket; this event would reverse the pressure on
the cd1 helix, retract it to the “off” position, and cause the release of
the ISP-ED. The ef helix stays at the open position until the product
exits the QP pocket (Fig. 4, step 4).
An important concept of this hypothesis is that the ISP-ED remains
ﬁxed at the QP site or b-position until the transfers of the second elec-
tron and protons from ubiquinol are completed, which effortlessly
explains the high ﬁdelity of the bifurcation of the electron pathway.
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with a great deal of biochemical, biophysical and genetic evidence:
(1) it provides a functional explanation for the extraordinary se-
quence conservation of the cd1 helix. (2) A logical consequence of
this hypothesis is that the reduction of b hemes precedes that of
cyt c1, as shown by the pre-steady state kinetic analysis [52,77–79].
(3) It agrees well with the observations that mutations introduced
into the ISP-ED binding surface mostly affect the ET kinetics be-
tween the ISP and cyt c1 but rarely inﬂuence the substrate binding,
as in RsK329A of R. sphaeroides [57], ScW142 of yeast [80], RsL286
and RsI292 of R. sphaeroides [81], RsK329 of R. sphaeroides [82], ScY279
of yeast (RcY302 in R. capsulatus) [6,7] and RsT160 of R. sphaeroides
[83]. (4) The hypothesis predicts that limiting the movement of the
cd1 helix leads tomodiﬁcation in the activity of the complex depending
on the size of substitution, as seen in RsS155 of R. sphaeroides [75]
and in RcG158 of R. capsulatus [84]. (5) Since antimycin is known to
act remotely at the QN site, it would be difﬁcult to explain how
antimycin could completely inhibit steady state bc1 activity, especially
in the context of ISP head domain undergoing a free motion. The ob-
served redox-dependency of ISP-ED conformational switch shows an
immobilized ISP-ED when bc1 is fully reduced, which readily explains
the strict inhibition of bc1 by antimycin.
Despite its simplicity as a control mechanism for bifurcation of
electron ﬂow at the QP site, this hypothesis does not adequately de-
ﬁne the signaling pathway that triggers the capture and release of
ISP-ED under physiological conditions. One possibility is that the ET
from hemes bL to bH causes protein conformational changes in the
cd1 helix and allows or forces the reduced ISP-ED to move from the
b-position to the c1-position to be oxidized [85,86]. Such a redox-
induced conformational change in the cyt b subunit has yet to gain di-
rect experimental support. A second possibility involves the binding of
the substrate QH2 to and exit of the reaction product Q from the QP
site, leading to capture and release of the ISP-ED [32].4. Interaction with substrates, lipids, inhibitors and metal ions
4.1. Interaction with cytochrome c
Despite the presumed transient interaction between bc1 and cyt c,
the crystal structures of bc1 in complex with either isoform-1 or -2 of
cyt c of S. cerevisiae were obtained to 2.97 Å resolution for the oxi-
dized cyt c and to 1.9 Å resolution for the reduced cyt c, respectively
[87,88]. It should be mentioned that in both cases the complex was
crystallized in the presence of a bound Fv fragment derived from a
monoclonal antibody and QP site inhibitor stigmatellin. As expected,
the cyt c binds to the c1 subunit of bc1. Surprisingly, however, the
binding is sub-stoichiometric with one cyt c bound to one c1 subunit,
while the second site on the bc1 dimer remains unoccupied or possi-
bly exhibits very low occupancy or severe disorder. The binding
forces were characterized as mostly nonpolar in nature. The close
spatial arrangement of the two cytochromes reduces the distance be-
tween the CBC atoms of the two respective heme vinyl groups to
4.5 Å and the distance between the two iron centers to 17.4 Å. Fur-
thermore, the observed interplanar angle of the heme groups is 55°,
suggesting a direct and rapid heme-to-heme electron transfer at a
calculated rate of up to 8.3×106 s−1. In the structure, no direct inter-
action has been observed between subunits QCR6 and cyt c; the for-
mer is a small acidic protein thought to be involved in cyt c binding.
In the reduced state, the dimer structure is asymmetric, as the bind-
ing of monovalent cyt c is correlated with conformational changes in
the ISP-ED and subunit QCR6 and with a higher number of interfacial
water molecules bound to cyt c1. There exists a mobility mismatch at
the interface, with disordered charged residues on the cyt c side and
ordered ones on the cyt c1 side, which could be signiﬁcant for transient
interactions [88].4.2. Interaction with ubiquinone at the QN site
Assignments of bound substrate ubiquinone (Q) have only been
made to the QN site. Initial indication for bound Q came from the dif-
ference density map between antimycin-bound and native crystals
[12], as a negative density appeared in a pocket in the TM region of
cyt b next to the bH heme site, which represented part of a ubiquinone
molecule that is bound in the native crystal but is displaced by bound
antimycin A. This suggests that the antimycin binding site partly
overlaps the quinone reduction site QN. In the yeast structure [19], a
Q6 (ubiquinone with six isoprenoid repeats) was ﬁtted into the elec-
tron density in the QN site. In bovine and R. sphaeroides bc1, a Q2 was
identiﬁed [21,27,58].
As no ubiquinone was added, the natural substrate identiﬁed in
the native bc1 crystal (1NTZ, Table 1) was obviously retained during
puriﬁcation and crystallization. In the reﬁned bovine bc1 structure [27],
a piece of electron density was located at the QN site of the cyt b subunit
more than 5σ above the mean, into which a ubiquinone molecule
with its ﬁrst two isoprenoid repeats was ﬁtted. The two possible ori-
entations of the planar ubiquinone ring could not be distinguished from
the shape of the electron density (Fig. 3C). The average B factor of
the bound ubiquinone is twice as large as its immediate protein envi-
ronment, suggesting most likely a lower than 50% occupancy in the
crystal. The quinone ring is nearly perpendicular to the plane of the
phenyl ring of BtF220 and to that of heme bH; the former forms an
Ar–Ar pair with the ubiquinone (3.0 Å), and the latter has the closest
distance of 4.2 Å. There are three H-bonds formed between the bound
ubiquinone and the QN site residues BtD228, BtH201 and BtS205; some
of these H-bonds are mediated bywatermolecules. The two isoprenoid
repeats that were visible in the electron density are in contact with res-
idues BtP18, BtS35, BtG38, BtM190, BtL197, and the bH heme. The van der
Waals surface of thematrix side of these TMhelices, particularly in cyt b,
features channels leading to the QN site and serving as possible proton
uptake pathways. Conformational changes in residues contacting
bound quinone, as exhibited in crystal structures of yeast and bovine
bc1, implicate possible mechanisms for proton uptake from the matrix
into the QN pocket [27].
In the Rsbc1 structure the natural substrate Q bound to the crystal-
line bc1 is estimated to have 70% occupancy based on the comparison
of average B factor of the Q to side chain atoms of surrounding,
interacting residues [21]. The quinone molecules are roughly perpen-
dicular to the parallel planes of RsF216 and heme bH on one side and
parallel to theplane of RsF244 on theother side.When the sixmonomer-
ic bc1 structures from a crystallographic asymmetric unit are aligned,
the positions and orientations of bound Q are different; the largest
positional and rotational displacements are 1.3 Å and 38°, respectively.
Residue RsH217 (BtH201) forms H-bonds with Q molecules with the
O2–NE2 distances in the range of 2.2–2.4 Å, indicating that the imidaz-
ole ring of RsH217 follows the motion of Q, consistent with its observed
conformational ﬂexibility.
4.3. Interaction with bound lipid and detergent molecules
Cyt bc1 is an integral part of the cellular membrane and conse-
quently, lipid molecules play an essential role in its function [89,90].
In eukaryotic cells, a characteristic phospholipid is cardiolipin, which
primarily exists in mitochondria and was shown to be essential for
the function of bc1 [14]. Crystal structures of bc1 from various species
have revealed bound lipid molecules [21,91]. The roles of these
bound lipid molecules are proposed to be twofold: promoting struc-
tural integrity of the complex and stimulating enzyme activity. Struc-
tural assignment and functional analysis for ﬁve crystallographically
resolved bound lipid molecules were described for yeast bc1 [91]:
two phosphatidylethanolamines (PE), one phosphatidylcholine (PC),
one phosphatidyinositol (PI), and one cardiolipin (CL) and one deter-
gent molecule DDM. These molecules are bound to the TM region at
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that are present at the dimer interface. Their head groups are bound to
the protein surface in regions with positive electrostatic potential. The
assignments were solely based on the appearance of electron density.Two lipid molecules have been described in considerable detail in
the yeast complex: a PI molecule was found to bind in an unusual
interhelical position near the ﬂexible linker region of the ISP and a
CL is positioned at the entrance of a proposed proton uptake site.
1289D. Xia et al. / Biochimica et Biophysica Acta 1827 (2013) 1278–1294The mutagenesis analysis of the CL site showed that CL binding is crit-
ical for the respiratory super complex formation [92].
In crystals of Rsbc1, ordered lipid molecules are often found on the
boundary surface between symmetry-related dimers, at the dimer
or subunit interfaces, and in surface depressions [21]. One lipid mol-
ecule was positively identiﬁed on the N-side of the membrane and in-
cluded in the model. However, additional lipids that are only partially
recognizable at both sides of the membrane were excluded in ﬁnal
models. The lipid molecule bound at the cytoplasmic surface of cyt b
is modeled as a lauryl oleoyl phosphatidyl ethanolamine (PE); its
head group aligns with the surface plane of the cytoplasmic leaﬂet
of the membrane and its fatty acid chains ﬂank the TM helices B
and G of cyt b (Fig. 3D). The exact identities of the fatty acids are un-
known but the assignment as PE is supported by comparing it to the
lipids present in bovine and yeast bc1. The phosphate group is hydro-
gen bonded to two highly conserved consecutive tyrosine residues
(RsY117 and RsY118), and the lipid head group is further stabilized
by the side chain of RsR358 by forming an ion pair with the lipid
phosphate.
At the N-terminal end of the ef1 insertion in cyt b, which is unique
to bc1 of bacteria, the side chain of RsW313 forms a stacked pair with
its symmetry-mate from a neighboring dimer at a distance of 3.8 Å.
This pair is symmetrically ﬂanked by at least six pieces of extra elec-
tron density, most likely stemming from bound lipid or detergent
molecules [21]. A strontium ion, clearly conﬁrmed by its anomalous
signal, sits right above the indole rings of the tryptophan pair. Its
exact coordination environment cannot be resolved, but might involve
the head groups of two pairs of putative lipid molecules. We observed
the tryptophan pair formation in all crystal forms, and the presence of
strontium ions seems to strengthen the interaction but is not required.4.4. Interaction with QN and QP site inhibitors
As a central component of the cellular respiratory chain, the bc1
complex became an easy target for numerous natural antibiotics, as
a result of constant battle for survival over the course of evolution. Ex-
amples of natural compounds that speciﬁcally target the bc1 complex
are antimycin A, strobilurin, myxothiazol, and stigmatellin. Many of
the earlier functional and mechanistic studies of the bc1 complex
were facilitated by the use of these inhibitors, which block ET at se-
lected points [93]. Structural analysis of bc1 complexes also beneﬁted
from these inhibitors, as they stabilize certain conformations at a
given state. By manipulating differences in uptake between the host
and pathogens, some of the inhibitors or their derivatives have been
developed into anti-fungal and anti-parasitic agents and are used
in agriculture to control fungal or bacterial diseases and in medicine
to treat infections.
Historically, bc1 inhibitors were classiﬁed based on their effects
on bL-heme spectrum and impact on the redox potential of the ISP,
due to a lack of understanding of the underlying process [94]. On
the basis of structural information, bc1 inhibitors are currently divid-
ed into QP site inhibitors (P), the QN site inhibitors (N) and the dual
site inhibitors (PN) [58]. An increasing body of structural evidence
starting with the ﬁrst structures of bc1 [12] followed by a number ofFig. 5. Structures of core proteins of bovine mitochondrial bc1 complex. (A) Ribbon represen
related by an intradomain approximate twofold rotational axis perpendicular to the plane
similar orientation as the core-1 subunit in (A). (C) Structure of core-1 (cyan) and core-2 (
axis. The two molecules are associated such that the N-terminal domain of core-1 is fa
ball-and-stick models, which is detailed in (E). (D) Electrostatic potential surface representa
as in (C). Red surface represents negative potential and blue positive. (E) Structural arrange
the two α helices, αA (green) and αD (red) that are separated by more than 50 residues, c
helices come together in the 3-D structure and are joined by BtR287 and BtK286 from the cor
are anchored to the TM region of the complex by recruiting and incorporating peptides from
(yellow) provides additional interactions with the core-1 subunit.high resolution inhibitor bound bc1 complex structures suggested
that the inﬂuence of the inhibitor on the mobility of the ISP-ED was
systematic. Accordingly, all known QP site inhibitors can be divided
into two subgroups [57,58], namely those that ﬁx the conformation
of the ISP-ED in the b-position (Pf-type) and those that mobilize it
(Pm-type). In the latter case, the ISP-EDmay be found in the c1-position
(PDB IDs: 3L70, 3L71, and 3L72) but could also be anywhere between
the b and c1-position (PDB IDs: 1SQP and 1SQQ).
The class of known Pf inhibitors encompasses stigmatellin, UHDBT,
HDBT, NQNO, famoxadone, JG144, fenamidone, ascochlorin and iodo-
crocacin-D. The class of Pm inhibitors contains the well-known natural
inhibitor myxothiazol but also the synthetic compounds methoxy-
acrylate stilbene and thewidely used pesticides azoxystrobin, kresoxim
methyl, triﬂoxystrobin, and triazolone. This group contains derivatives
of strobilurin, whose structure–activity relationship advanced the re-
search in respiratory chain complex III inhibitors. Given the consistency
of the mode of binding in this group, it could be expected that all
methoxy-acrylates, methoxy-carbamates, oximino-acetates, oximino-
acetamides and benzyl-carbamates would belong to this group. The
class of N inhibitors is comprised of compounds that occupy the QN
site. This group is still rather small and starts with the natural inhibitor
antimycin but also contains NQNO and ascochlorin, for which crystal
structures were determined (Table 1). No structural information is
currently available that would illuminate how a number of natural
inhibitors like funiculosin or the important pesticides cyano-imidazole
(cyazofamid) and sulfamoyl-triazole (amisulbrom) might bind. The
class of PN inhibitors is essentially not a new class, as members of
this group are listed in both the P and N classes (Table 1). Its presence
only underlines the fact that some inhibitors have features (just as
the quinol/quinone pair) that allow them to bind to both active sites.
This group includes NQNO, ascochlorin and tridecyl-stigmatellin
(observed in b6f) [95].4.5. Interaction with metal ions
Crystallization of bc1 complexes often includes the use of metal
ions, some of which have been found incorporated into the resulting
crystal structures. When incubated with mother liquor containing
200 μM ZnCl2 for seven days, the crystalline chicken bc1 complex spe-
ciﬁcally binds Zn2+ ions at two identical sites or one per monomer
in the dimer [96]. Zinc binding occurs close to the QP site and is likely
to be the reason for the inhibitory effect on the activity of bc1 observ-
able during zinc titration [97,98]. The Zn2+ ion binds to a hydrophilic
area between cytochromes b and c1 (PDB ID: 3H1K) and is coordinated
by GgH212 of cyt c1, GgH268, GgD253, and GgE255 of cyt b, and might in-
terferewith the egress of protons from theQP site to the intermembrane
aqueous medium. No Zn2+ was bound at the zinc binding motif of
the putative MPP active site of core-1 and core-2 for chicken bc1 after
prolonged soaking [96] nor was it found in the native bovine or yeast
structures [12,19].
Crystals of Rsbc1 grown in the presence of strontium ions revealed
several Sr2+ binding sites. One site that is not present in mitochon-
drial bc1 but appears to be conserved in photosynthetic bacteria is
on cyt c1 [21]. The strontium ion, conﬁrmed by the appearance of atation of the structure of the core-1 subunit showing two domains of the α-β structure
of the diagram. (B) Structure of the core-2 in the form of a ribbon diagram showing in
coral) heterodimer viewed parallel to the intersubunit approximate twofold rotational
cing the C-terminal domain of core-2. The putative zinc-binding motif is shown as
tion of the core-1 and core-2 heterodimer. The surface is shown in the same orientation
ment of the zinc-binding motif in the core subunits of the bc1 complex. Residues from
ontribute to the zinc-binding motif. Residues important for Zn binding from these two
e-2 subunit (yellow). (F) Attachment of core proteins to the bc1 complex. Core subunits
subunit 7 (red) and cyt c1 (blue) into a β-sheet in the core-1 subunit. The ISP subunit
1290 D. Xia et al. / Biochimica et Biophysica Acta 1827 (2013) 1278–1294strong anomalous signal from the data set collected above the stron-
tium absorption edge, is accessible from the periplasm and coordinated
by side chains of RsD8, RsE14, and RsE129 aswell as by the backbone car-
bonyl oxygen atom of residue RsV9 in a distorted octahedron. At the
N-terminal end of the ef1 insertion in cyt b, the side chain of RsW313
forms a stacked pair with its symmetry-mate from a neighboring
dimer at a distance of 3.8 Å. A strontium ion, clearly conﬁrmed by
its anomalous signal, sits right above the indole rings of the tryptophan
pair. In this case the role of strontium ions seems to reinforce the inter-
action of the tryptophan pair.
5. Structures of supernumerary subunits and their functional
implications
Common to all bc1 complexes are the three subunits that contain
redox prosthetic groups. In higher organisms, there are additional
subunits with more than half of the total molecular mass of the com-
plex, which are called supernumerary subunits. The role of these sub-
units has been a matter of debate. Since they are not required for
the ET function of bc1, it was previously assumed that the additional
subunits had structural rather than functional roles. The supernumer-
ary subunits include two large extrinsic proteins named core-1 and
core-2, and another four to six smaller subunits of molecular mass
under 15 kDa. Most supernumerary subunits are not embedded in
the membrane, but peripherally localized at the membrane surfaces,
mostly at the matrix side of the membrane.
5.1. Structures of core-1 and core-2 subunits of mitochondrial bc1
The core proteins contribute to more than one-third of the total
mass of the bc1 complex. The function of the core proteins in
non-plant species is not understood fully. They are, however, re-
quired for full activity and stability of the bc1 complex [99]. In yeast,
the core proteins were shown to be required for assembly of the com-
plex [100]. In plants, the core proteins have a unique peptidase func-
tion [2,101].
The core-1 and core-2 subunits of bovine bc1 are synthesized in
the cytosol as precursor proteins of 480 and 453 amino acid residues,
respectively, which are proteolytically processed as they are being
transported into mitochondria by removing 34 and 14 residues,
respectively, from the N-termini of core-1 and core-2 precursors.
Core-1 and core-2 share 21% sequence identity and expectedly, their
three-dimensional structures are remarkably similar (Fig. 5A and B).
Each of the core subunits consists of two structural domains of about
equal size and almost identical folding topology, which are also relat-
ed by approximately twofold rotation symmetry, even though only
about 10% of the residues are chemically identical. Both domains
are folded into one mixed β-sheet of ﬁve or six β-strands, ﬂanked
by three α-helices on one side and one α-helix from the other do-
main on the other side.
The overall shape of each core protein resembles a bowl. In the
assembled Btbc1 complex, the N-terminal domain of core-1 interacts
with the C-terminal domain of core-2, and vice versa (Fig. 5C). Core-1
and core-2 enclose a large, acidic cavity that was also observed by elec-
tron microscopy [29] (Fig. 5D). Because the two internal approximate
twofold rotation axes of core-1 and core-2 differ in direction by 14.5°,
the two bowls representing these proteins come together in the form
of a ball with a crevice leading to the internal cavity (Fig. 5D). The crev-
ice is ﬁlled with peptide fragments that were assigned as part of
subunit 9, a signal peptide of the ISP subunit [12]. The amino acid resi-
dues lining the wall of the cavity are mostly hydrophilic.
Yeast COR1 and QCR2 have sequence homologies of 51% and 50%
to the corresponding core-1 and core-2 subunits of bovine bc1, re-
spectively [19]. The differences between the two species are most
pronounced in the C-terminal domain of QCR2. The subunit is 68 res-
idues shorter than the corresponding bovine core-2; its N-terminaldomain has a ﬁve-stranded β sheet, whereas the bovine core-2 is
six-stranded. In the bovine complex the cleaved signal peptide of
the ISP (subunit 9) is located in the crevice between the core-1 and
core-2 proteins [12], the binding of which is stabilized by hydropho-
bic interactions with this β sheet. Polar or charged residues are pres-
ent at the corresponding positions in yeast [19]. Thus, this cavity
formed between COR1 and QCR2 is larger in yeast and open to the
bulk solvent and no electron density was found for a retained signal
peptide.
The core-1 and core-2 heterodimer ofMtbc1 is thought to be a relic
of the broad family of metalloproteases. In particular, the core pro-
teins of mammalian bc1 complexes are homologous to the subunits
of the general mitochondrial matrix processing peptidase (MPP), which
cleaves signal peptides of nucleus-encoded proteins after import into
the mitochondrion. MPP belongs to a family of metalloendoproteases
whose members include insulin-degrading enzymes from mammals
and protease III from bacteria. Mammalian and fungal MPP are soluble
heterodimers of α- and β-subunits localized in the mitochondrial
matrix. Both subunits of MPP are required for the protease activity,
but the active site is part of the β-subunit. The core-1 protein of the bo-
vine bc1 complex has 56% sequence identity to theβ-subunit of ratMPP,
38% to yeast, and 42% to potato, whereas the core-2 protein is 27% iden-
tical to the α-subunit of rat MPP, 28% to yeast, and 30% to potato. Inter-
estingly, the sequence identity of the bovine core proteins to the related
MPP subunits of yeast is signiﬁcantly higher than to that of the yeast
subunits itself [19].We can therefore expect that theMPPs of these spe-
cies are similar in structure to the bovine core-1 and core-2 subunits.
In plant mitochondria, the MPP activity is membrane-bound and is an
integral part of the bc1 complex [2].
The bovine core-1 features a inversed putative Zn-binding motif
consisting of two α helices (αA and αD, Fig. 5E) with a modiﬁed
zinc-binding sequence of BTY57XXE60H61-(X)75-E137, compared to
the consensus sequence of HXXEH-(X)74–76-E [102]. In yeast, the motif
has a rather different sequence of ScN70XXK73N74-(X)63-Q137. In addi-
tion, the yeast subunit lacks the loop ScF64–N73 of its bovine homologue.
With the rather conserved zinc-binding motif in the bovine core-1
subunit, it was expected that the heterodimeric core-1 and core-2 may
possess proteolytic activitywhen it is freed from the bc1 complex. Indeed,
the core-1 and core-2 heterodimer of bovine bc1, when treated with tri-
ton X-100, displays MPP activity that is divalent metal ion dependent
[99] and inhibited by N-terminal signal peptide of the ISP precursor [3].
The dimeric core subunits are anchored to the membrane by
recruiting peptide fragments from the N-terminus of subunit 7 and
C-terminus of the cyt c1 subunit and incorporating the two peptides
into the β sheet in the N-terminal portion of the core-1 subunit
(Fig. 5F). Additionally, the N-terminal peptide of the ISP subunit stays
in close proximity to the crevice between core-1 and core-2, making
additional contacts with the core-1 subunit.
5.2. Structures of other supernumerary subunits
In addition to the two core subunits, smaller supernumerary sub-
units have also been resolved in various crystal structures. For the bo-
vine complex, structures of all eleven subunits were determined,
whereas subunit 11 in avian structures and subunit QCR10, the equiva-
lent of subunit 11 in bovine bc1, in yeast aremissing (Table 1). Genet-
ic and biochemical characterizations of supernumerary subunits
were often carried out in yeast, illuminating some of their biological
functions.
Subunit 6 (also named QPK, 13.4 kDa, QCR7 in yeast) was shown
to be on the matrix side of the membrane. It is entirely helical and
consists of four helices with connecting loops (Fig. 6A). It attaches
on the matrix side to exposed residues of helices F, G, and H of one cyt
b subunit in one monomer, while also making contact with core-1
and core-2 of the symmetry-related monomer (Fig. 1A). Because of
its position in the bc1 complex, this subunit is conceivably necessary
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ous environment on the matrix side, as partial removal of subunit 6 by
proteolysis decouples redox-linked proton pumping [103].
Subunit 7 (also named QPC, 9.6 kDa, QCR8 in yeast) was identiﬁed
as a quinol-binding protein, as it forms adducts with various azido-
ubiquinone derivatives [104]. In yeast, mutagenesis of QCR8 indicated
an important role of this subunit in the assembly of a functional enzyme
and in inhibitor myxothiazol binding, suggesting an impaired QP site
[105,106]. The crystal structure shows that subunit 7 contributes to
both the matrix and TM regions. The C-terminal 50 residues of subunit
7 form a long, bent TM helix, and its N-terminal part associates with
the core-1 protein as part of a β sheet (Figs. 6B and 5F), serving as one
of the membrane anchors for the subunits in the matrix region. The
TM portion of the subunit is in direct contact with TM helices G and H
of the cyt b subunit, forming a hydrophobic depression that could inter-
act with hydrophobic molecules such as ubiquinone.
Subunit 8 (also called hinge-protein, 9.2 kDa, QCR6 in yeast) was
previously thought to support ET from cyt c1 to cyt c by mediating
contacts between the two components. This is the only supernumer-
ary subunit that is located on the positive side of the membrane. Crys-
tal structures have conﬁrmed its location and its interaction with the
cyt c1 subunit. Subunit 8 is entirely helical, consisting of three helices
(Fig. 6C); it forms a hairpin like structure, which is stabilized by a
couple of disulﬁde bonds. The subunit is highly acidic with a large num-
ber of glutamate and aspartate residues. In the structure, it exclusively
interacts with the cyt c1 subunit (Fig. 1A). Interestingly, in the yeast
structure of bc1 complexed with cyt c, subunit QCR6 is not in direct
contact with the substrate, calling into question the idea that this
subunit mediates interaction between cyt c1 and cyt c.
Subunit 9 (8 kDa) is the signal peptide from the ISP precursor after
proteolytic processing, and thus may have a role in incorporating the
ISP subunit into the bc1 complex. It has also been hypothesized that
during assembly of the bc1 complex, the ISP precursor protein may
be used to recruit the heterodimeric core proteins as a suicide bait
[99]. However, this subunit is not present in the yeast bc1. In the crys-
tal structure, subunit 9 is mostly associated with the core-2 subunit.
The structure of subunit 9 is in large part a random coil with a pairFig. 6. Structures of supernumerary subunits of the Btbc1 complex in ribbon presentation (A)of β-strands (Fig. 6D) that extends a β-sheet of core-2. A part of the
subunit falls into the crevice between core-1 and core-2 and the
modeled C-terminus of subunit 9 is not close to the N-terminus of
the ISP subunit. From a crystallographic point of view, this subunit
falls into the category of the least well-determined portion of the bc1
structure.
Subunit 10 (7.2 kDa, QCR9 in yeast) is also called the cyt c1 associ-
ated protein. Deletion of QCR9 in yeast leads to poor growth on
non-fermentable carbon sources and the yeast exhibited very low
wild-type bc1 activity [107]. These results indicate that QCR9 is re-
quired for formation of a fully functional complex. The crystal struc-
ture of bc1 revealed that subunit 10 is made of two helices: the
N-terminal helix runs parallel to the negative side of membrane sur-
face, the middle helix is transmembrane, and its C-terminus exten-
sion reaches out to interact with cyt c1 on the positive side of the
membrane (Figs. 6E and 1A).
Subunit 11 (6.3 kDa, QCR10 in yeast) is preserved in the crystal
structure of Btbc1 but is not seen in those of avian and yeast, presum-
ably due to different puriﬁcation or crystallization procedures. This
subunit features a single TM helix (Fig. 6F) that attaches perhaps
loosely to the periphery of the complex.
6. Concluding remarks
Fifteen years have passed since the beginning of an era of crystal
structure determination of bc1, which not only beautifully illustrated
the architecture of this integral membrane protein and conﬁrmed
the essence of the Q-cycle, it has also surprised us with structural fea-
tures that was previously inaccessible using various experimental
methods and shed new light on the mechanisms of bc1 function and
its inhibition. Crystallographic method has once again demonstrated
its power in providing atomic resolution snap shots of bc1 trapped as
various reaction intermediates, whichwere necessary for reconstructing
the reaction sequence of bc1 function.Understanding the exact sequence
of events during substrate processing holds the valuable promise of pro-
viding insight into processes of aging, mitochondrial diseases, apoptosis,
pest control and possibly other phenomena.Subunit 6, (B) subunit 7, (C) subunit 8, (D) subunit 9, (E) subunit 10, and (F) subunit 11.
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